Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia

References

• UNAIDSGlobal AIDS Update 2016GenevaUNAIDS2016
   Google Scholar
• Joint United Nations Programme on HIV/AIDSFact Sheet-Latest Statistics on the Status of the AIDS EpidemicGenevaJoint United Nations Programme on HIV/AIDS2017
   Google Scholar
• EDHSEthiopia Demographic and Health Survey, 2016 HIV prevalence report: Central Statistical AuthorityAddis Ababa, Ethiopia, and Rockville, Maryland, USACSA and ICF2016
   Google Scholar
• Medina-TorneSGanesanABarahonaICrum-CianfloneNFHypertension is common among HIV-infected persons, but not associated with HAARTJ Int Assoc Physicians AIDS Care20121112025
   Google Scholar
• NüeschRWangQElziLRisk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)J Acquir Immune Defic Syndr201362439640423288033
   PubMed Web of Science ®Google Scholar
• BrownTTColeSRLiXAntiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort studyArch Intern Med2005165101179118415911733
   PubMedGoogle Scholar
• LedergerberBFurrerHRickenbachMFactors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort StudyClin Infect Dis200745111111917554711
   PubMed Web of Science ®Google Scholar
• GrinspoonSCarrACardiovascular risk and body-fat abnormalities in HIV-infected adultsN Engl J Med20053521486215635112
   PubMed Web of Science ®Google Scholar
• WandHCalmyACareyDLMetabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infectionAIDS200721182445245318025881
   PubMed Web of Science ®Google Scholar
• RabkinMNishtarSScaling up chronic care systems: leveraging HIV programs to support noncommunicable disease servicesJ Acquir Immune Defic Syndr201157Suppl 2S87S9021857304
   PubMed Web of Science ®Google Scholar
• NigatuTIntegration of HIV and noncommunicable diseases in health care delivery in low- and middle-income countriesPrev Chronic Dis20129E9322554408
   PubMed Web of Science ®Google Scholar
• SmartTHIV and non communicable diseases (NCDs)London, UKNAM2011
   Google Scholar
• Antiretroviral Therapy Cohort CollaborationLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesLancet2008372963529329918657708
   PubMed Web of Science ®Google Scholar
• LohseNHansenABPedersenGSurvival of persons with and without HIV infection in Denmark, 1995-2005Ann Intern Med20071462879517227932
   PubMed Web of Science ®Google Scholar
• AounSRamosEHypertension in the HIV-infected patientCurr Hypertens Rep20002547848110995524
   PubMedGoogle Scholar
• TershakovecAMFrankIRaderDHIV-related lipodystrophy and related factorsAtherosclerosis2004174111015135244
   PubMed Web of Science ®Google Scholar
• CalzaLManfrediRChiodoFInsulin resistance and diabetes mellitus in HIV-infected patients receiving antiretroviral therapyMetab Syndr Relat Disord20042424125018370693
   PubMed Web of Science ®Google Scholar
• GrinspoonSMechanisms and strategies for insulin resistance in acquired immune deficiency syndromeClin Infect Dis200337Suppl 2S85S9012942379
   PubMed Web of Science ®Google Scholar
• BaekkenMOsISandvikLOektedalenOHypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapyJ Hypertens200826112126213318854751
   PubMed Web of Science ®Google Scholar
• MateenFJKantersSKalyesubulaRHypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in UgandaJ Hypertens20133171372137823615323
   PubMed Web of Science ®Google Scholar
• DioufACournilABa-FallKDiabetes and hypertension among patients receiving antiretroviral treatment since 1998 in Senegal: prevalence and associated factorsIsrn Aids2012201218
   Google Scholar
• Mary-KrauseMCotteLSimonAPartisaniMCostagliolaDClinical Epidemiology Group from the French Hospital DatabaseIncreased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected menAIDS200317172479248614600519
   PubMed Web of Science ®Google Scholar
• DAD Study GroupFriis-MøllerNReissPClass of antiretroviral drugs and the risk of myocardial infarctionN Engl J Med2007356171723173517460226
   PubMed Web of Science ®Google Scholar
• DenueAMuazuJGashauWNkamiDAjayiNAEffects of highly active antiretroviral therapy (HAART) on blood pressure changes and its associated factors in HAART naive HIV-infected patients in north eastern NigeriaArch Appl Sci Res20124314471452
   Google Scholar
• CurrierJScherzerRBacchettiPRegional adipose tissue and lipid and lipoprotein levels in HIV-infected womenJ Acquir Immune Defic Syndr2008481354318197118
   PubMed Web of Science ®Google Scholar
• KotlerDPHIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patientsJ Acquir Immune Defic Syndr200849Suppl 2S79S8518725816
   PubMed Web of Science ®Google Scholar
• ShenoyARamapuramJTUnnikrishanBEffect of lipodys-trophy on the quality of life among people living with HIV (PLHIV) on highly active antiretroviral therapyJ Int Assoc Provid AIDS Care201413547147523722086
   PubMedGoogle Scholar
• DalyRFreemantleJKohGStradlingCvan der LindeMTaylorSAre traditional risk factors associated with cardiovascular events in HIV positive subjectsHIV Med2012135253
   Web of Science ®Google Scholar
• FactorSHLoYSchoenbaumEKleinRSIncident hypertension in older women and men with or at risk for HIV infectionHIV Med201314633734623294666
   PubMed Web of Science ®Google Scholar
• HadiganCDietary habits and their association with metabolic abnormalities in human immunodeficiency virus-related lipodystrophyClin Infect Dis200337Suppl 2S101S10412942382
   PubMed Web of Science ®Google Scholar
• SavèsMRaffiFCapeauJFrançoisRJacquelineCFactors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapyClin Infect Dis200234101396140511981737
   PubMed Web of Science ®Google Scholar
• KibretKTMesfinYMPrevalence of hypertension in Ethiopia: a systematic meta-analysisPublic Health Rev20153611429450042
   PubMedGoogle Scholar
• YemaneTBelachewTAsaminewBBefekaduOType II diabetes mellitus in Jimma Town, southwest Ethiopia.Ethiopia J Health Sci2007172
   Google Scholar
• AwokeAAwokeTAlemuSMegabiawBPrevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: a community based cross-sectional studyBMC Cardiovasc Disord201212111323186560
   PubMed Web of Science ®Google Scholar
• MisganawAMariamDHAliAArayaTEpidemiology of major non-communicable diseases in Ethiopia: a systematic reviewJ Health Popul Nutr2014321124847587
   PubMed Web of Science ®Google Scholar
• MohammedAEShenkuteTYGebisaWCDiabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest EthiopiaDiabetes Metab Syndr Obes2015819725926749
   PubMed Web of Science ®Google Scholar
• WHOGlobal Database on Body Mass IndexGenevaWHO2011
   Google Scholar
• WHOWaist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8–11 December 2008GenevaWHO2011
   Google Scholar
• FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
   PubMed Web of Science ®Google Scholar
• WHODefinition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF ConsultationGenevaWorld Hearth Organization2006
   Google Scholar
• ZannouDMDenoeudLLacombeKIncidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in BeninAntivir Ther200914337138019474471
   PubMed Web of Science ®Google Scholar
• GuptaVBiswasASharmaSKMetabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patientsInt J STD AIDS2011221464921364067
   PubMed Web of Science ®Google Scholar
• SalehianBBilasJBazarganMAbbasianMPrevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitorsJ Natl Med Assoc2005978108816173323
   PubMed Web of Science ®Google Scholar
• WHODiabetes Country ProfilesGenevaWHO2016
   Google Scholar
• IDFIDF Diabetes AtlasBrusselsInternational Diabetes Federation2017
   Google Scholar
• TienPCSchneiderMFColeSRAntiretroviral therapy exposure and incidence of diabetes mellitus in the Women’s Interagency HIV StudyAIDS200721131739174517690572
   PubMed Web of Science ®Google Scholar
• da SilvaEFBassichettoKCLewiDSLipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patientsArq Bras Cardiol200993211311819838487
   PubMed Web of Science ®Google Scholar
• SachithananthanVLohaEGoseMPrevalence of Diabetes Mellitus, Hypertension and Lipodystrophy in HAART Receiving HIV Patients in Southern EthiopiaInt STD Res Rev201311111
   Google Scholar
• Tomažic˘JSilic˘AKarnerPLipodystrophy and metabolic abnormalities in Slovenian HIV-infected patientsWien Klin Wochenschr200411621–2275575915628647
   PubMed Web of Science ®Google Scholar
• RamezaniAMohrazMYadegariniaDPrevalence of dyslipidemia and metabolic abnormalities in HIV-infected patientsActa Medica Iranica20094728388
   Google Scholar
• KabatiCMauriceHMselleTUrioMEvaluation of the prevalence of insulin dependent diabetes mellitus in HIV/AIDS patients in Muhimbili National Hospital, Dar es Salaam, TanzaniaTaJONAS: Tanzania Journal of Natural and Applied Sciences201212164173
   Google Scholar
• TzurFChowersMMekoriYHershkoAPrevalence of diabetes mellitus among Ethiopian-born HIV patients in IsraelJ Int AIDS Soc201215Suppl 411
   Google Scholar
• DanciulescuRMusatMCristescuVPoianaCThe prevalence of diabetes mellitus in patients infected with human immunodeficiency virus on treatment with antiretoviral drugsEndocrine Abstracts201126P736
   Google Scholar
• WuP-YHungC-CLiuW-CMetabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factorsJ Antimicrob Chemother20126741001100922232517
   PubMed Web of Science ®Google Scholar
• JuliusHBasuDRicciEThe burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg HospitalCurr HIV Res20119424725221631427
   PubMed Web of Science ®Google Scholar
• ManuthuEMJoshiMDLuleGNKarariEPrevalence of dyslipidemia and dysglycaemia in HIV infected patientsEast Afr Med J2008851101718543521
   PubMedGoogle Scholar
• PuttawongSPrasithsirikulWVadcharavivadSPrevalence of lipodystrophy in Thai-HIV infected patientsJ Med Assoc Thai200487660561115279336
   PubMedGoogle Scholar
• HowellSJSearJWFoëxPHypertension, hypertensive heart disease and perioperative cardiac riskBr J Anaesth200492457058315013960
   PubMed Web of Science ®Google Scholar
• MendisSGlobal Status Report on Noncommunicable Diseases 2014GenevaWorld Health Organization2014
   Google Scholar
• MulunehATHaileamlakATessemaFPopulation based survey of chronic non-communicable diseases at gilgel gibe field research center, southwest EthiopiaEthiopia J Health Sci2012224718
   PubMedGoogle Scholar
• NyaberaRYongaGMwangemiFBukachiFEvaluation of a project integrating cardiovascular care into HIV programmesCardiovasc J Afr2011143S17
   Google Scholar
• SaniMMuhammadSOkeahialamBEffects of HAART on cardiovascular risk profile of HIV/AIDS patients in Aminu Kano Teaching Hospital, Kano, NigeriaCardiovasc J Afr201122S22
   Google Scholar
• AdewoleOEzeSBetikuYLipid profile in HIV/AIDS patients in NigeriaAfr Health Sci201010214414921326966
   PubMed Web of Science ®Google Scholar
• HejaziNRajikanRKwok ChoongCLSaharSMetabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional surveyBMC Public Health201313175823947428
   PubMed Web of Science ®Google Scholar
• Arruda JuniorERLacerdaHRMouraLCRisk factors related to hypertension among patients in a cohort living with HIV/AIDSBraz J Infect Dis201014328128720835513
   PubMed Web of Science ®Google Scholar
• BloomfieldGSHoganJWKeterAHypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western KenyaPLoS One201167e2228821779407
   PubMed Web of Science ®Google Scholar
• PalaciosRSantosJGarciaAImpact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patientsHIV Med200671101516313287
   PubMed Web of Science ®Google Scholar
• BergersenBMSandvikLDunlopOBirkelandKBruunJNPrevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patientsEur J Clin Microbiol Infect Dis2003221273173614610658
   PubMed Web of Science ®Google Scholar
• ColomaACAlvarezMARoca-CusachsACDomingoPPPuigMCPrevalence of arterial hypertension and lipid profile in HIV patientsMedicina clinica20081311868168419087824
   PubMed Web of Science ®Google Scholar
• CahnPLeiteORosalesAMetabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAARTBraz J Infect Dis201014215816620563442
   PubMed Web of Science ®Google Scholar
• Nsakashalo-SenkweMSiziyaSGomaFMSongoloPMukonkaVBabaniyiOCombined prevalence of impaired glucose level or diabetes and its correlates in Lusaka urban district, Zambia: a population based surveyInt Arch Med201141221226931
   PubMedGoogle Scholar
• ButtAAMcginnisKRodriguez-BarradasMCHIV infection and the risk of diabetes mellitusAIDS200923101227123419444074
   PubMed Web of Science ®Google Scholar
• RasmussenLDMathiesenERKronborgGPedersenCGerstoftJObelNRisk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort studyPLoS One201279e4457522984529
   PubMed Web of Science ®Google Scholar
• HowardAAFloris-MooreMArnstenJHDisorders of glucose metabolism among HIV-infected womenClin Infect Dis200540101492149915844072
   PubMed Web of Science ®Google Scholar
• JustmanJEBenningLDanoffAProtease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected womenJ Acquir Immune Defic Syndr200332329830212626890
   PubMed Web of Science ®Google Scholar
• CapeauJBouteloupVKatlamaCTen-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatmentAIDS201226330331422089377
   PubMed Web of Science ®Google Scholar
• de WitSSabinCAWeberRIncidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyDiabetes Care20083161224122918268071
   PubMed Web of Science ®Google Scholar
• SamarasKWandHLawMEmerySCooperDCarrAPrevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemiaDiabetes Care200730111311917192343
   PubMed Web of Science ®Google Scholar
• OmechBSempaJCastelnuovoBPrevalence of HIV-associated metabolic abnormalities among patients taking first-line antiretroviral therapy in UgandaIsrn Aids20122012416
   Google Scholar
• CraneHMGrunfeldCWilligJHImpact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical careAIDS201125218519521150555
   PubMed Web of Science ®Google Scholar
• ShishaniKDajaniRKhaderYHypertension risk assessment in the largest ethnic groups in JordanJ Immigr Minor Health2013151434821959712
   PubMed Web of Science ®Google Scholar
• AhanekuGOsujiCUAnisiubaBCIkehVOOguejioforOCAhanekuJEEvaluation of blood pressure and indices of obesity in a typical rural community in eastern NigeriaAnn Afr Med201110212021691018
   PubMedGoogle Scholar